We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

EKF Highlighting Its Expanding Range Of Liquid Stable Clinical Chemistry Reagents At Hospitalar 2015

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

EKF Diagnostics will be highlighting its expanding Stanbio central laboratory clinical chemistry range at Hospitalar, 19–22 May, Sao Paulo, Brazil.  This range includes a large selection of clinical chemistry assays, controls and calibrators, which are fully compatible with most major brand open channel chemistry analyzers. 

On Stand K77, EKF will discuss new additions to its Stanbio range of liquid-stable clinical chemistry reagents (Liquicolor® and Liqui-UV®) which are designed for maximum stability and ease of use. These include a new diabetes biomarker test that provides a 2-3 week indicator of average blood glucose - the Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor® test as well as the new Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay for early sepsis identification.

EKF will also be showcasing its wide range of point-of-care (POC) hematology analyzers. These deliver quick and laboratory accurate results to aid diagnoses of anemia and associated conditions within a variety of near-patient settings, including hospitals, clinics, blood banks and in challenging field-based conditions. 

EKF will demonstrate its portfolio of easy-to-use and reliable hemoglobin/hematocrit analyzers designed to meet a range of POC testing needs. These include the UltraCrit Plus™ which is a high accuracy hematocrit (Hct) measurement device for blood donor screening. Using reagent-less cuvettes to obtain a result from a single drop of blood within 30 seconds, its accuracy of ≤0.4% Hct, has been shown to decrease both “false deferrals” and “false accepts”. UltraCrit Plus™ is the first and only hematocrit/hemoglobin device to use ultrasound technology, which enables high accuracy results with an imprecision of <0.8%.

Other EKF hemoglobin analyzers to be demonstrated include HemoPoint H2 and DiaSpect Tm. A hand held device delivering results in <2 seconds, DiaSpect Tm is the world’s fastest hemoglobin measurement system offering laboratory quality performance for anemia screening in all climatic conditions. Storing over 4000 patient results, the HemoPoint H2 is designed for use in blood banks, clinics and hospitals and provides immediate lab-quality results for both hemoglobin and hematocrit from one test. Its proprietary “soft load” cuvette holder is designed to minimize contamination of the meter.